PURPOSE: Wide-field swept-source (SS) OCT angiography (OCTA) was compared with ultrawide-field (UWF) fluorescein angiography (FA) for evaluating neovascularization (NV) before and after panretinal photocoagulation (PRP) in eyes with treatment-naive proliferative diabetic retinopathy (PDR). DESIGN: Prospective, observational, consecutive case series. PARTICIPANTS: Patients with treatment-naive PDR. METHODS: Patients were imaged using the SS OCTA 12 × 12-mm field of view (PLEX Elite 9000; Carl Zeiss Meditec, Inc, Dublin, CA) at baseline and at 1 week, 1 month, and 3 months after PRP. Select eyes were imaged with 5 SS OCTA 12 × 12-mm scans to create posterior pole montages. Ultrawide-field fundus photography and UWF FA were obtained at baseline and 3 months after PRP. MAIN OUTCOME MEASURES: Neovascularization visualized using wide-field SS OCTA and UWF FA. RESULTS: From January through May 2018, wide-field SS OCTA was performed on 20 eyes with treatment-naive PDR from 15 patients. The en face SS OCTA 12 × 12-mm vitreoretinal interface (VRI) slab images showed NV at baseline in 18 of 20 eyes (90%). Of the remaining 2 eyes, the posterior pole montage captured peripheral NV in one eye, and in the other eye, no evidence of NV was detected with either UWF FA or SS OCTA. After PRP, both SS OCTA and FA demonstrated similar progression or regression of NV, but SS OCTA provided more detailed visualization of the vascular changes. CONCLUSIONS: Neovascularization in PDR can be identified at baseline and imaged serially after PRP using wide-field SS OCTA. In patients with a high clinical suspicion for PDR, wide-field SS OCTA likely will be the only imaging method needed for diagnosis and longitudinal evaluation of NV.
PURPOSE: Wide-field swept-source (SS) OCT angiography (OCTA) was compared with ultrawide-field (UWF) fluorescein angiography (FA) for evaluating neovascularization (NV) before and after panretinal photocoagulation (PRP) in eyes with treatment-naive proliferative diabetic retinopathy (PDR). DESIGN: Prospective, observational, consecutive case series. PARTICIPANTS: Patients with treatment-naive PDR. METHODS:Patients were imaged using the SS OCTA 12 × 12-mm field of view (PLEX Elite 9000; Carl Zeiss Meditec, Inc, Dublin, CA) at baseline and at 1 week, 1 month, and 3 months after PRP. Select eyes were imaged with 5 SS OCTA 12 × 12-mm scans to create posterior pole montages. Ultrawide-field fundus photography and UWF FA were obtained at baseline and 3 months after PRP. MAIN OUTCOME MEASURES: Neovascularization visualized using wide-field SS OCTA and UWF FA. RESULTS: From January through May 2018, wide-field SS OCTA was performed on 20 eyes with treatment-naive PDR from 15 patients. The en face SS OCTA 12 × 12-mm vitreoretinal interface (VRI) slab images showed NV at baseline in 18 of 20 eyes (90%). Of the remaining 2 eyes, the posterior pole montage captured peripheral NV in one eye, and in the other eye, no evidence of NV was detected with either UWF FA or SS OCTA. After PRP, both SS OCTA and FA demonstrated similar progression or regression of NV, but SS OCTA provided more detailed visualization of the vascular changes. CONCLUSIONS: Neovascularization in PDR can be identified at baseline and imaged serially after PRP using wide-field SS OCTA. In patients with a high clinical suspicion for PDR, wide-field SS OCTA likely will be the only imaging method needed for diagnosis and longitudinal evaluation of NV.
Authors: Steven A Agemy; Nicole K Scripsema; Chirag M Shah; Toco Chui; Patricia M Garcia; Jessica G Lee; Ronald C Gentile; Yi-Sing Hsiao; Qienyuan Zhou; Tony Ko; Richard B Rosen Journal: Retina Date: 2015-11 Impact factor: 4.256
Authors: Yanping Huang; Qinqin Zhang; Mariana R Thorell; Lin An; Mary K Durbin; Michal Laron; Utkarsh Sharma; Giovanni Gregori; Philip J Rosenfeld; Ruikang K Wang Journal: Ophthalmic Surg Lasers Imaging Retina Date: 2014 Sep-Oct Impact factor: 1.300
Authors: Hamid-Reza Moein; Eduardo A Novais; Carl B Rebhun; Emily D Cole; Ricardo N Louzada; André J Witkin; Caroline R Baumal; Jay S Duker; Nadia K Waheed Journal: Retina Date: 2018-12 Impact factor: 4.256
Authors: Xinzhi Zhang; Jinan B Saaddine; Chiu-Fang Chou; Mary Frances Cotch; Yiling J Cheng; Linda S Geiss; Edward W Gregg; Ann L Albright; Barbara E K Klein; Ronald Klein Journal: JAMA Date: 2010-08-11 Impact factor: 56.272
Authors: Jennifer K Sun; Michael M Lin; Jan Lammer; Sonja Prager; Rutuparna Sarangi; Paolo S Silva; Lloyd Paul Aiello Journal: JAMA Ophthalmol Date: 2014-11 Impact factor: 7.389
Authors: Jay C Wang; Inês Laíns; Joana Providência; Grayson W Armstrong; Ana R Santos; Pedro Gil; João Gil; Katherine E Talcott; João H Marques; João Figueira; Demetrios G Vavvas; Ivana K Kim; Joan W Miller; Deeba Husain; Rufino Silva; John B Miller Journal: Am J Ophthalmol Date: 2017-10-06 Impact factor: 5.258
Authors: Daniel Shu Wei Ting; Gavin Siew Wei Tan; Rupesh Agrawal; Yasuo Yanagi; Nicole Ming Sie; Chee Wai Wong; Ian Yew San Yeo; Shu Yen Lee; Chui Ming Gemmy Cheung; Tien Yin Wong Journal: JAMA Ophthalmol Date: 2017-04-01 Impact factor: 7.389
Authors: WooJhon Choi; Kathrin J Mohler; Benjamin Potsaid; Chen D Lu; Jonathan J Liu; Vijaysekhar Jayaraman; Alex E Cable; Jay S Duker; Robert Huber; James G Fujimoto Journal: PLoS One Date: 2013-12-11 Impact factor: 3.240
Authors: Jonathan F Russell; Hasenin Al-Khersan; Yingying Shi; Nathan L Scott; John W Hinkle; Kenneth C Fan; Cancan Lyu; William J Feuer; Giovanni Gregori; Philip J Rosenfeld Journal: Am J Ophthalmol Date: 2020-03-13 Impact factor: 5.258
Authors: Jonathan F Russell; Nathan L Scott; Justin H Townsend; Yingying Shi; Giovanni Gregori; Ashley M Crane; Harry W Flynn; Jayanth Sridhar; Philip J Rosenfeld Journal: Retina Date: 2021-08-01 Impact factor: 3.975
Authors: Hasenin Al-Khersan; Jonathan F Russell; Thomas A Lazzarini; Nathan L Scott; John W Hinkle; Nimesh A Patel; Nicolas A Yannuzzi; Benjamin J Fowler; Rehan M Hussain; Anita Barikian; Jayanth Sridhar; Stephen R Russell; Luis J Haddock; William E Smiddy; Seenu M Hariprasad; Yingying Shi; Liang Wang; William Feuer; Giovanni Gregori; Philip J Rosenfeld Journal: Am J Ophthalmol Date: 2020-12-11 Impact factor: 5.258
Authors: Ying Cui; Ying Zhu; Edward S Lu; Rongrong Le; Inês Laíns; Raviv Katz; Jay C Wang; Itika Garg; Yifan Lu; Rebecca Zeng; Dean Eliott; Demetrios G Vavvas; Deeba Husain; Joan W Miller; Leo A Kim; David M Wu; John B Miller Journal: Ophthalmology Date: 2021-02-26 Impact factor: 14.277
Authors: Ying Cui; Ying Zhu; Jay C Wang; Yifan Lu; Rebecca Zeng; Raviv Katz; Filippos Vingopoulos; Rongrong Le; Inês Laíns; David M Wu; Dean Eliott; Demetrios G Vavvas; Deeba Husain; Joan W Miller; Leo A Kim; John B Miller Journal: Br J Ophthalmol Date: 2020-06-26 Impact factor: 5.908
Authors: Ying Cui; Ying Zhu; Jay C Wang; Yifan Lu; Rebecca Zeng; Raviv Katz; David M Wu; Demetrios G Vavvas; Deeba Husain; Joan W Miller; Leo A Kim; John B Miller Journal: Transl Vis Sci Technol Date: 2019-11-15 Impact factor: 3.283
Authors: Hasenin Al-Khersan; Jonathan F Russell; Yingying Shi; Jayanth Sridhar; Giovanni Gregori; Harry W Flynn; Philip J Rosenfeld Journal: Am J Ophthalmol Case Rep Date: 2020-04-14